cell-mediated immunity to herpes simplex virus type 1 ( hsv-1 ) was assessed by a lymphocytotoxicity 51-cr-release microassay procedure , using the ma-160 human prostatic adenoma cell line chronically infected with hsv-1 and its parent cell line as control .
C0020966
cell-mediated immunity
C0301896
lymphocytotoxicity